Article Sidebar
Published:
Sep 6, 2024DOI:
10.4314/tjpr.v23i7.1Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Tong-Xie-Yao-Fang improves chronic intestinal fibrosis in mice with colitis through CRH-R2-mediated IL-6/STAT3 signaling pathway
Abstract
Purpose: To investigate the potential mechanism of action of Tong-Xie-Yao-Fang (TXYF) on inflammation-related intestinal fibrosis in mice. In addition, to examine dextran sodium sulfate (DSS) induction and the stimulation of human intestinal fibroblasts (CCD-18Co) by transforming growth factorβ1 (TGF-β1).
Methods: Chronic colitis in C57BL/6 mice was induced by administering 2 % DSS and TXYF extract (11.2 g/kg per day). An intestinal fibrosis cell model was constructed by stimulating CCD-18Co cells with TGF-β1 (10 ng/mL). The status and weight loss of colitis of the mice was assessed by Disease Activity Index (DAI) while colonic tissue injury and fibrosis were assessed using hematoxylin-eosin (H&E) staining and Masson’s trichrome staining. Relative expression levels of corticotrophin-releasing hormone receptor 2 (CRH-R2) and Interleukin 6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) in colon tissues and CCD-18Co cells were determined using Western blot. A cell model of intestinal fibrosis was constructed by stimulating CCD-18Co cells with TGF-β1 (10 ng/mL). At the same time, the cells were subjected to the intervention of TXYF drug-containing serum (TXYF-DS).
Results: TXYF significantly improve the pathological changes, weight loss, and DAI score of colon tissue in DSS induced colitis mice (p < 0.05). The expression levels of IL-6 and p-STAT3 were significantly reduced, while the expression level of CRH-R2 was upregulated in the mouse colon tissue (p < 0.05). At the cellular level, TXYF-DS intervention significantly reduced cell mortality and mitigated the degree of cell fibrosis (p < 0.05). Furthermore, the expression level of CRH-R2 was up-regulated while that of IL-6 and p-STAT3 were down-regulated.
Conclusion: TXYF ameliorates chronic intestinal fibrosis in colitis-afflicted mice by restricting IL6/STAT3 signaling pathway whilst upregulating CRH-R2 expression
